Find clinical documents

or

Document type:
RAG rating:question mark
Output type:
Medicine / Guideline Indication RAG rating Document type Place
Adalimumab Uveitis - non-infectious (NHSE) Red NICE technology appraisal Hertfordshire and West Essex ICB
Aflibercept Wet AMD Red Prescribing guideline Hertfordshire and West Essex ICB
Aflibercept Vascular endothelial growth factor A inhibitor (anti-VEGF), Wet Age-related Macular Degeneration, Diabetic macular oedema, Macular oedema secondary to retinal vein occlusion (branch RVO or central RVO), Choroidal neovascularisation (CNV) associated with pathological myopia Red Decision document Hertfordshire and West Essex ICB
Bevacizumab Vascular endothelial growth factor A inhibitor (anti-VEGF), Wet Age-related Macular Degeneration, Diabetic macular oedema, Macular oedema secondary to retinal vein occlusion (branch RVO or central RVO), Choroidal neovascularisation (CNV) associated with pathological myopia Red Decision document Hertfordshire and West Essex ICB
Bevacizumab Wet AMD Red Prescribing guideline Hertfordshire and West Essex ICB
Biologic and Biosimilar Medicines Where indicated n/a Patient information Hertfordshire and West Essex ICB
Blepharoplasty and Brow Lift n/a Clinical policy Hertfordshire and West Essex ICB
Blepharoplasty and Brow Lift Prior Approval Form n/a Prior approval form Hertfordshire and West Essex ICB
Brolucizumab Wet AMD Red Prescribing guideline Hertfordshire and West Essex ICB
Brolucizumab Wet Age-related Macular Degeneration, Diabetic macular oedema Red Decision document Hertfordshire and West Essex ICB
Cataract Surgery n/a Clinical policy Hertfordshire and West Essex ICB
Chalazia (meibomian cysts) removal n/a Clinical policy Hertfordshire and West Essex ICB
Chalazia Prior Approval Form n/a Prior approval form Hertfordshire and West Essex ICB
Dexamethasone intravitreal implant Diabetic macular oedema Red NICE technology appraisal Hertfordshire and West Essex ICB
Dexamethasone intravitreal implant Uveitis - non-infectious Red NICE technology appraisal Hertfordshire and West Essex ICB
Dysthyroid Eye Disease n/a Clinical policy Hertfordshire and West Essex ICB
Faricimab Wet AMD Red Prescribing guideline Hertfordshire and West Essex ICB
Faricimab Wet Age-related Macular Degeneration, Diabetic macular oedema Red Decision document Hertfordshire and West Essex ICB
Fluocinolone intravitreal implant Diabetic macular oedema Red NICE technology appraisal Hertfordshire and West Essex ICB
Fluocinolone intravitreal implant Uveitis - non-infectious Red NICE technology appraisal Hertfordshire and West Essex ICB
Lutein and Antioxidants Eye Supplements for AMD Double Red Prescribing guideline Hertfordshire and West Essex ICB
Ocriplasmin Vitreomacular traction Double Red NICE technology appraisal Hertfordshire and West Essex ICB
Ranibizumab Diabetic retinopathy Double Red NICE technology appraisal Hertfordshire and West Essex ICB
Ranibizumab Wet AMD Red Prescribing guideline Hertfordshire and West Essex ICB
Ranibizumab Vascular endothelial growth factor A inhibitor (anti-VEGF), Wet Age-related Macular Degeneration, Diabetic macular oedema, Macular oedema secondary to retinal vein occlusion (branch RVO or central RVO), Choroidal neovascularisation (CNV) associated with pathological myopia Red Decision document Hertfordshire and West Essex ICB
Wet AMD Wet AMD Red Prescribing guideline Hertfordshire and West Essex ICB